药品集中采购制度与“两票制”政策衔接的关键问题分析

Analysis of the Key Problems in the Connection between the Centralized Procurement System of Drugs and the "Two-Invoice" Policy

"两票制"改革正在全国层面逐步推开,作为政策落实的起始环节,如何将药品集中采购制度与"两票制"改革合理衔接是此项改革顺利实施的关键。本文将从目前"两票制"政策与药品采购环节的植入程度入手,重点讨论"如何应对生产企业提高出厂价"以及"企业处罚的合法、合理性"两大问题,以期为两项政策的优化衔接提出合理建议。

＂Two-Invoice＂reform is gradually pushed at the national level, as the starting point of policy implementation, How to combine the centralized purchasing system of drugs with the ＂two-Invoice＂ policy is the key to the smooth implementation of this reform. This paper will start from the association between the reform and the centralized purchasing system of drugs, and focusing on ＂how to deal with the production enterprises to improve ex-factory price＂ and ＂the legality and rationality of corporate punishment＂two issues, with a view to the two policies to optimize the convergence of reasonable recommendations.